61b9a93c354f8.pdf
DOI:
Mavjud emas
1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. e spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805–15. doi: https://doi.org/ 10.1016/S14744422(07)70216-8
2. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390–6. doi: https://doi.org/10.1001/archneur. 63.3.390
3. Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 2015; 84: 1165–73. doi: https://doi.org/10.1212/WNL. 0000000000001367
4. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964–8. doi: https://doi.org/ 10.1001/archneur.63.7.964
5. Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010; 16: 1229–36. doi: https://doi.org/10.1177/ 1352458510376640